Company Monitoring Page for AbbVie

latest headlines for company on cafepharma

Halozyme shares drop after AbbVie punts a failed program; Celgene buys another cancer drug
Endpoints
Mon, 11/21/16 - 11:27 am
Tags:
Halozyme, AbbVie, Celgene, marizomib
What puts a new drug launch in line for victory? Ask Gilead, Biogen and J&J
Fierce Pharma
Thu, 11/17/16 - 10:01 am
Tags:
Gilead Sciences, Biogen, JNJ, drug launches, AbbVie, Sovaldi, Imbruvica, Tecfidera
After The Deluge, Hep C Players Look For Opportunity
Seeking Alpha
Thu, 11/17/16 - 09:57 am
Tags:
hepatitis C, Gilead Sciences, AbbVie, Epclusa, glecaprevir/pibrentasvir, sofosbuvir/velpatasvir
AbbVie's Humira a Step Closer to Approval in Europe
Yahoo/GuruFocus
Wed, 11/16/16 - 09:50 am
Tags:
AbbVie, Humira, Europe
AbbVie's pan-genotypic hep C prospect shines in trials, putting the heat on rival Gilead
Fierce Pharma
Tue, 11/15/16 - 09:36 am
Tags:
AbbVie, hepatitis C, Gilead Sciences, Epclusa
AbbVie reports positive 8-week data in HCV
BioPharma Dive
Mon, 11/14/16 - 12:00 pm
Tags:
AbbVie, hepatitis C, glecaprevir/pibrentasvir
J&J, GSK stumble coming out of the gate with mixed PhIII rheumatoid arthritis data for sirukumab
Endpoints
Sun, 11/13/16 - 12:00 pm
Tags:
JNJ, GSK, rheumatoid arthritis, sirukumab, AbbVie, Humira
AbbVie: Take That Coherus!
Barron's
Tue, 11/8/16 - 09:58 am
Tags:
AbbVie, Coherus Biosciences, Humira, biosimilars
In October TV pharma ad spending, AbbVie's Humira and Pfizer's Lyrica continue to dominate
Fierce Pharma
Mon, 11/7/16 - 09:40 am
Tags:
drug ads, AbbVie, Humira, Pfizer, Lyrica
AbbVie Receives FDA Orphan Drug Designation for Investigational Medicine Veliparib for the Treatment of Advanced Squamous Non-Small Cell Lung Cancer
Yahoo
Sat, 11/5/16 - 02:10 pm
Tags:
AbbVie, veliparib, advanced squamous non-small cell lung cancer
3 Things AbbVie's Management Said While Its Stock Got Hammered
Motley Fool
Sat, 10/29/16 - 01:23 pm
Tags:
AbbVie, earnings, Humira, Imbruvica, Viekira Pak
AbbVie Inc. Q3 Results: Good but Not Good Enough
Motley Fool
Fri, 10/28/16 - 05:43 pm
Tags:
AbbVie, earnings
AbbVie's Viekira Pak Sales Plummet in Q3
Motley Fool
Fri, 10/28/16 - 05:22 pm
Tags:
AbbVie, Viekira Pak, eanrings
AbbVie Could Be The Next Gilead
Seeking Alpha
Thu, 10/27/16 - 10:14 pm
Tags:
AbbVie, Gilead Sciences
Boehringer flags PhIII success for another Humira knockoff, setting up a crowded field of cheaper rivals — eventually
Endpoints
Wed, 10/26/16 - 09:16 pm
Tags:
Boehringer Ingelheim, Humira, BI 695501, AbbVie, rheumatoid arthritis
No surprise: AbbVie turns cold shoulder to a messy rheumatoid arthritis partnership with Ablynx
Endpoints
Thu, 10/20/16 - 09:34 am
Tags:
AbbVie, rheumatoid arthritis, Ablynx, vobarilizumab
AbbVie Is Under Duress With Fierce Competition
Seeking Alpha
Thu, 10/20/16 - 09:20 am
Tags:
AbbVie, Humira, biosimilars, Amgen, Baxalta, Shire
Roche, AbbVie: Venclyxto Receives Positive Opinion From Committee
Yahoo/GuruFocus
Sat, 10/15/16 - 12:23 pm
Tags:
Roche, AbbVie, Venclyxto, CHMP, chronic lymphocytic leukemia, CLL, venetoclax
Could J&J's recent news about its rheumatoid arthritis and Crohn's disease drugs threaten AbbVie's Humira?
Motley Fool
Thu, 10/13/16 - 11:05 am
Tags:
JNJ, rheumatoid arthritis, Crohn's Disease, AbbVie, Humira, sirukumab
AbbVie Receives FDA Ranking for Hepatitis C Therapy
Yahoo/GuruFocus
Mon, 10/3/16 - 09:51 pm
Tags:
AbbVie, FDA, hepatitis C, glecaprevir/pibrentasvir

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.